Follow
Peiyuan Zheng
Peiyuan Zheng
Verified email at mails.tsinghua.edu.cn
Title
Cited by
Cited by
Year
Development of small-molecule BRD4 degraders based on pyrrolopyridone derivative
J Zhang, P Chen, P Zhu, P Zheng, T Wang, L Wang, C Xu, J Zhou, ...
Bioorganic Chemistry 99, 103817, 2020
232020
Design, synthesis and biological evaluation of pyridone–aminal derivatives as MNK1/2 inhibitors
X Yuan, H Wu, H Bu, P Zheng, J Zhou, H Zhang
Bioorganic & Medicinal Chemistry 27 (7), 1211-1225, 2019
162019
Design, synthesis and biological evaluation of imidazo [1, 5-a] pyrazin-8 (7H)-one derivatives as BRD9 inhibitors
P Zheng, J Zhang, H Ma, X Yuan, P Chen, J Zhou, H Zhang
Bioorganic & Medicinal Chemistry 27 (7), 1391-1404, 2019
102019
Proteolysis-targeting chimeras mediate the degradation of bromodomain and extra-terminal domain proteins
Y Yang, Z Wu, P Chen, P Zheng, H Zhang, J Zhou
Future Medicinal Chemistry 12 (18), 1669-1683, 2020
62020
Research progress of selective small molecule bromodomain-containing protein 9 inhibitors
M Hui, Z Jian, Z Peiyuan, W Zhenwei, Z Huibin
Future Medicinal Chemistry 10 (8), 895-906, 2018
52018
A Biodegradable Antigen Nanocapsule Promotes Anti‐Tumor Immunity via the cGAS‐STING Pathway
X Jia, H Chen, M Wu, L Wang, T Li, J Ma, X Yi, P Tan, P Zheng, J Du
Advanced Functional Materials 33 (10), 2212085, 2023
42023
A polymer-based antigen carrier activates two innate immune pathways for adjuvant-free subunit vaccines
H Chen, L Wang, X Zhao, H Jiang, M Wu, Y Ding, X Jia, Y Zhang, T Li, ...
ACS nano 18 (12), 9160-9175, 2024
12024
The system can't perform the operation now. Try again later.
Articles 1–7